Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Emergence of a new group CTX-M enzyme in Romania and risk factors for extended spectrum beta-lactamase producing E. coli infections.

Miftode E, Dorneanu O, Badescu A, Ghibu L, Leca D, Vremera T, Mereuţă A.

Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):477-80.

PMID:
23077940
2.

Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.

Pitout JD.

Expert Rev Anti Infect Ther. 2012 Oct;10(10):1165-76. doi: 10.1586/eri.12.110. Review.

PMID:
23199402
3.

Community-acquired CTX-M-15-type ESBL-producing Escherichia coli meningitis: a case report and literature review.

Elaldi N, Gozel MG, Kolayli F, Engin A, Celik C, Bakici MZ, Vahaboglu H.

J Infect Dev Ctries. 2013 May 13;7(5):424-31. doi: 10.3855/jidc.2820. Review.

4.

Escherichia coli sequence type 131: epidemiology and challenges in treatment.

Qureshi ZA, Doi Y.

Expert Rev Anti Infect Ther. 2014 May;12(5):597-609. doi: 10.1586/14787210.2014.899901. Epub 2014 Apr 2. Review.

PMID:
24694052
5.

Extended-spectrum β-lactamase infections during pregnancy: a growing threat.

Eppes CS, Clark SL.

Am J Obstet Gynecol. 2015 Nov;213(5):650-2. doi: 10.1016/j.ajog.2015.03.020. Epub 2015 Mar 11. Review.

PMID:
25771212
6.

Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective.

Brolund A.

Infect Ecol Epidemiol. 2014 Oct 1;4. doi: 10.3402/iee.v4.24555. eCollection 2014. Review.

Supplemental Content

Support Center